Drugs List

Drugs A-Z List - X
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs List [Browse by brand or generic name]
Xalatan, Xalatan Multi-Pack latanoprost ophthalmic (Pronunciation: la TAN oh p - FDA

Description : Latanoprost is a prostaglandin F2α analogue. Its chemical name is isopropyl-(Z)­7...

  • Indications
  • XALATAN Sterile Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
  •   Read More
Xalatan, Xalatan Multi-Pack latanoprost ophthalmic (Pronunciation: la TAN oh p - Multum

Description : Latanoprost is a prostaglandin F2α analogue. Its chemical name is isopropyl-(Z)­7...

  • Indications
  • XALATAN Sterile Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
  •   Read More
Xalatan, Xalatan Multi-Pack  latanoprost ophthalmic (Pronunciation: la TAN oh - FDA

Description : Latanoprost is a prostaglandin F2α analogue. Its chemical name is isopropyl-(Z)­7[(1R...

  • Indications
  • XALATAN Sterile Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
  •   Read More
Xalatan, Xalatan Multi-Pack latanoprost ophthalmic (Pronunciation: la TAN oh p - Multum

Description : Latanoprost is a prostaglandin F2α analogue. Its chemical name is isopropyl-(Z)­7[(1R...

  • Indications
  • XALATAN Sterile Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
  •   Read More
Xalkori crizotinib (Pronunciation: kriz OH ti nib) - FDA

Description : XALKORI (crizotinib) is an oral receptor tyrosine kinase inhibitor. The molecular formula f...

  • Indications
  • XALKORI is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by
  •   Read More
Xalkori crizotinib (Pronunciation: kriz OH ti nib) - Multum

Description : XALKORI (crizotinib) is an oral receptor tyrosine kinase inhibitor. The molecular formula f...

  • Indications
  • XALKORI is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detecte
  •   Read More
Xalkori crizotinib (Pronunciation: kriz OH ti nib) - FDA

Description : XALKORI (crizotinib) is an oral receptor tyrosine kinase inhibitor. The molecular formula for c...

  • Indications
  • XALKORI is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by
  •   Read More
Xarelto rivaroxaban (Pronunciation: RIV a ROX a ban) - FDA

Description : Rivaroxaban, a FXa inhibitor, is the active ingredient in XARELTO Tablets with the chemical...

  • Indications
  • Reduction Of Risk Of Stroke And Systemic Embolism In Nonvalvular Atrial Fibrillation XARELTO is indicated to reduce the risk of stroke and systemic embolism in patients w
  •   Read More
Xarelto rivaroxaban (Pronunciation: RIV a ROX a ban) - Multum

Description : Rivaroxaban, a FXa inhibitor, is the active ingredient in XARELTO Tablets with the chemical...

  • Indications
  • Reduction Of Risk Of Stroke And Systemic Embolism In Nonvalvular Atrial Fibrillation XARELTO is indicated to reduce the risk of stroke and systemic embolism in patients w
  •   Read More
Xarelto (rivaroxaban) Film-coated Oral Tablets - FDA

Description : Rivaroxaban, a FXa inhibitor, is the active ingredient in XARELTO Tablets with the chemical nam...

  • Indications
  • Reduction Of Risk Of Stroke And Systemic Embolism In Nonvalvular Atrial Fibrillation XARELTO is indicated to reduce the risk of stroke and systemic embolism in patients w
  •   Read More
Xarelto rivaroxaban (Pronunciation: RIV a ROX a ban) - Multum

Description : Rivaroxaban, a FXa inhibitor, is the active ingredient in XARELTO Tablets with the chemical nam...

  • Indications
  • Reduction Of Risk Of Stroke And Systemic Embolism In Nonvalvular Atrial Fibrillation XARELTO is indicated to reduce the risk of stroke and systemic embolism in patients w
  •   Read More
Xartemis XR oxycodone hydrochloride and acetaminophen) Tablets - FDA

Description : XARTEMIS XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets combine tw...

  • Indications
  • XARTEMIS XR is indicated for the management of acute pain severe enough to require opioid treatment and for which alternative treatment options are inadequate. Limitatio
  •   Read More
Xartemis XR oxycodone hydrochloride and acetaminophen - FDA

Description : XARTEMIS XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets combine two an...

  • Indications
  • XARTEMIS XR is indicated for the management of acute pain severe enough to require opioid treatment and for which alternative treatment options are inadequate. Limitatio
  •   Read More
Xeljanz  tofacitinib (Pronunciation: TOE fa SYE ti nib - Multum

Description : XELJANZ is the citrate salt of tofacitinib, a JAK inhibitor. Tofacitinib citrate is a white to...

  • Indications
  • Rheumatoid Arthritis XELJANZ (tofacitinib) is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inad
  •   Read More
Xeljanz  tofacitinib (Pronunciation: TOE fa SYE ti nib) - FDA

Description :   ...

  • Indications
  • Rheumatoid Arthritis XELJANZ (tofacitinib) is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inad
  •   Read More
Xeljanz tofacitinib (Pronunciation: TOE fa SYE ti nib) - Multum

Description : XELJANZ is the citrate salt of tofacitinib, a JAK inhibitor. Tofacitinib citrate is a white to...

  • Indications
  • Rheumatoid Arthritis XELJANZ (tofacitinib) is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inad
  •   Read More
Xeloda capecitabine (Pronunciation: KAP e SYE ta been) - FDA

Description : XELODA (capecitabine) is a fluoropyrimidine carbamate with antineoplastic activity. It is a...

  • Indications
  • Colorectal Cancer XELODA is indicated as a single agent for adjuvant treatment in patients with Dukes' C colon cancer who have undergone complete resection of the prim
  •   Read More
Xeloda capecitabine (Pronunciation: KAP e SYE ta been) - Multum

Description : XELODA (capecitabine) is a fluoropyrimidine carbamate with antineoplastic activity. It is a...

  • Indications
  • Colorectal Cancer XELODA is indicated as a single agent for adjuvant treatment in patients with Dukes' C colon cancer who have undergone complete resection of the prim
  •   Read More
Xeloda capecitabine (Pronunciation: KAP e SYE ta been) - FDA

Description : XELODA (capecitabine) is a fluoropyrimidine carbamate with antineoplastic activity. It is an or...

  • Indications
  • Colorectal Cancer XELODA is indicated as a single agent for adjuvant treatment in patients with Dukes' C colon cancer who have undergone complete resection of the prim
  •   Read More
Xeloda capecitabine (Pronunciation: KAP e SYE ta been) - Multum

Description : XELODA (capecitabine) is a fluoropyrimidine carbamate with antineoplastic activity. It is an or...

  • Indications
  • Colorectal Cancer XELODA is indicated as a single agent for adjuvant treatment in patients with Dukes' C colon cancer who have undergone complete resection of the prim
  •   Read More
Xenazine  tetrabenazine (Pronunciation: TET ra BEN a zeen) - FDA

Description : XENAZINE (tetrabenazine) is a monoamine depletor for oral administration. The molecular weight ...

  • Indications
  • XENAZINE is indicated for the treatment of chorea associated with Huntington's disease.
  •   Read More
Xenon Xe 133 Gas mixture of xenon gas (5%) in carbon dioxide (95%). - FDA

Description : Xenon Xe 133 Gas is supplied in a mixture of xenon gas (5%) in carbon dioxide (95%). It is cont...

  • Indications
  • Inhalation of Xenon Xe 133 Gas has proved valuable for the evaluation of pulmonary function and for imaging the lungs. It may also be applied to assessment of cerebral flow.
  •   Read More
Xenon Xe 133 Gas For Diagnostic Use - FDA

Description : Xenon Xe 133 Gas is supplied in a mixture of xenon gas (5%) in carbon dioxide (95%). It is cont...

  • Indications
  • Inhalation of Xenon Xe 133 Gas has proved valuable for the evaluation of pulmonary function and for imaging the lungs. It may also be applied to assessment of cerebral flow.
  •   Read More
Xeomin incobotulinumtoxinA (Pronunciation: IN koe BOT ue - FDA

Description : The active ingredient of XEOMIN is botulinum toxin type A produced from fermentation of Hal...

  • Indications
  • Cervical Dystonia XEOMIN (incobotulinumtoxinA) is indicated for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck
  •   Read More
Xeomin incobotulinumtoxinA (Pronunciation: IN koe BOT ue - Multum

Description : The active ingredient of XEOMIN is botulinum toxin type A produced from fermentation of Hal...

  • Indications
  • Cervical Dystonia XEOMIN (incobotulinumtoxinA) is indicated for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck
  •   Read More
Xeomin incobotulinumtoxinA (Pronunciation: IN koe BOT ue - FDA

Description : The active ingredient of XEOMIN is botulinum toxin type A produced from fermentation of Hall st...

  • Indications
  • Cervical Dystonia XEOMIN (incobotulinumtoxinA) is indicated for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck
  •   Read More
Xeomin  incobotulinumtoxinA (Pronunciation: IN koe BOT ue - Multum

Description : The active ingredient of XEOMIN is botulinum toxin type A produced from fermentation of Hall st...

  • Indications
  • Cervical Dystonia XEOMIN (incobotulinumtoxinA) is indicated for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck
  •   Read More
Xerese (acyclovir and hydrocortisone) Cream 5%/1% - FDA

Description : XERESE contains acyclovir, a synthetic nucleoside analogue active against herpes viruses, a...

  • Indications
  • XERESE (acyclovir and hydrocortisone cream) is indicated for the early treatment of recurrent herpes labialis (cold sores) to reduce the likelihood of ulcerative cold sores an
  •   Read More
Xerese  acyclovir and hydrocortisone topical (Pronunciati - Multum

Description : XERESE contains acyclovir, a synthetic nucleoside analogue active against herpes viruses, a...

  • Indications
  • XERESE (acyclovir and hydrocortisone cream) is indicated for the early treatment of recurrent herpes labialis (cold sores) to reduce the likelihood of ulcerative cold sores an
  •   Read More
Xerese acyclovir and hydrocortisone topical (Pronunciatio - FDA

Description : XERESE contains acyclovir, a synthetic nucleoside analogue active against herpes viruses, and h...

  • Indications
  • XERESE (acyclovir and hydrocortisone cream) is indicated for the early treatment of recurrent herpes labialis (cold sores) to reduce the likelihood of ulcerative cold sores an
  •   Read More
Xgeva denosumab (Xgeva) (Pronunciation: den OH sue mab) - FDA

Description : Xgeva (denosumab) is a human IgG2 monoclonal antibody that binds to human RANKL. Denosumab...

  • Indications
  • Bone Metastasis From Solid Tumors Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumors. Limitation of Use
  •   Read More
Xgeva denosumab (Xgeva) (Pronunciation: den OH sue mab) - Multum

Description : Xgeva (denosumab) is a human IgG2 monoclonal antibody that binds to human RANKL. Denosumab...

  • Indications
  • Bone Metastasis From Solid Tumors Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumors. Limitation of Use
  •   Read More
Xgeva denosumab (Xgeva) (Pronunciation: den OH sue mab) - FDA

Description : Xgeva (denosumab) is a human IgG2 monoclonal antibody that binds to human RANKL. Denosumab has ...

  • Indications
  • Bone Metastasis From Solid Tumors Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumors. Limitation of Use
  •   Read More
Xgeva denosumab (Xgeva) (Pronunciation: den OH sue mab - Multum

Description : Xgeva (denosumab) is a human IgG2 monoclonal antibody that binds to human RANKL. Denosumab has...

  • Indications
  • Bone Metastasis From Solid Tumors Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumors. Limitation of Use
  •   Read More
Xiaflex collagenase clostridium histolyticum (Pronunciatio - FDA

Description : XIAFLEX contains purified collagenase clostridium histolyticum, consisting of two microbial...

  • Indications
  • XIAFLEX is indicated for the treatment of adult patients with Dupuytren's contracture with a palpable cord. XIAFLEX is indicated for the treatment of adult men with Peyro
  •   Read More
Xiaflex collagenase clostridium histolyticum (Pronunciatio - Multum

Description : XIAFLEX contains purified collagenase clostridium histolyticum, consisting of two microbial...

  • Indications
  • XIAFLEX is indicated for the treatment of adult patients with Dupuytren's contracture with a palpable cord. XIAFLEX is indicated for the treatment of adult men with Peyro
  •   Read More
Xiaflex collagenase clostridium histolyticum (Pronunciatio - FDA

Description : XIAFLEX contains purified collagenase clostridium histolyticum, consisting of two microbial col...

  • Indications
  • XIAFLEX is indicated for the treatment of adult patients with Dupuytren's contracture with a palpable cord. XIAFLEX is indicated for the treatment of adult men with Peyro
  •   Read More
Xiaflex collagenase clostridium histolyticum (Pronunciatio - Multum

Description : XIAFLEX contains purified collagenase clostridium histolyticum, consisting of two microbial col...

  • Indications
  • XIAFLEX is indicated for the treatment of adult patients with Dupuytren's contracture with a palpable cord. XIAFLEX is indicated for the treatment of adult men with Peyro
  •   Read More
Xifaxan rifaximin (Pronunciation: rif AX i min) - FDA

Description : XIFAXAN tablets contain rifaximin, a non-aminoglycoside semi-synthetic, nonsystemic antibio...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN  and other antibacterial drugs, XIFAXAN when used to treat infection sh
  •   Read More
Xifaxan rifaximin (Pronunciation: rif AX i min) - Multum

Description : XIFAXAN tablets contain rifaximin, a non-aminoglycoside semi-synthetic, nonsystemic antibio...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN  and other antibacterial drugs, XIFAXAN when used to treat infection sh
  •   Read More
Xifaxan  rifaximin (Pronunciation: rif AX i min) - Multum

Description : XIFAXAN tablets contain rifaximin, a non-aminoglycoside semi-synthetic, nonsystemic antibiotic ...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of XIFAXAN and other antibacterial drugs, XIFAXAN when used to treat infection should
  •   Read More
Xigduo XR dapagliflozin and metformin HCl) Extended-release - FDA

Description : XIGDUO XR (dapagliflozin and metformin HCl extended-release) tablets contain two oral antih...

  • Indications
  • XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mel
  •   Read More
Xigduo XR dapagliflozin and metformin HCl) Extended-release - FDA

Description : XIGDUO XR (dapagliflozin and metformin HCl extended-release) tablets contain two oral antihyper...

  • Indications
  • XIGDUO XR (dapagliflozin and metformin HCl extended-release) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitu
  •   Read More
Xigris drotrecogin alfa (Pronunciation: droe tre KOE gin - FDA

Description : Xigris (drotrecogin alfa (activated)) is a recombinant form of human activated protein C. A...

  • Indications
  • Xigris (drotrecogin alfa) ® is indicated for the reduction of mortality in adult patients with severe sepsis (sepsis associated with acute organ dysfunction) who have
  •   Read More
Xigris drotrecogin alfa (Pronunciation: droe tre KOE gin - Multum

Description : Xigris (drotrecogin alfa (activated)) is a recombinant form of human activated protein C. A...

  • Indications
  • Xigris (drotrecogin alfa) ® is indicated for the reduction of mortality in adult patients with severe sepsis (sepsis associated with acute organ dysfunction) who have
  •   Read More
Xigris drotrecogin alfa (Pronunciation: droe tre KOE gin - FDA

Description : Xigris (drotrecogin alfa (activated)) is a recombinant form of human activated protein C. An es...

  • Indications
  • Xigris (drotrecogin alfa) ® is indicated for the reduction of mortality in adult patients with severe sepsis (sepsis associated with acute organ dysfunction) who have
  •   Read More
Xigris  drotrecogin alfa (Pronunciation: droe tre KOE gin - Multum

Description : Xigris (drotrecogin alfa (activated)) is a recombinant form of human activated protein C. An es...

  • Indications
  • Xigris (drotrecogin alfa) ® is indicated for the reduction of mortality in adult patients with severe sepsis (sepsis associated with acute organ dysfunction) who have
  •   Read More
Ximino (minocycline hydrochloride) Extended-Release Capsu - FDA

Description : The active ingredient in Ximino Extended-Release Capsules is minocycline hydrochloride, a semi ...

  • Indications
  • Indication Ximino is indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. To reduce
  •   Read More
Ximino minocycline hydrochloride) Extended-Release Capsul - FDA

Description : The active ingredient in Ximino Extended-Release Capsules is minocycline hydrochloride, a semi ...

  • Indications
  • Indication Ximino is indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. To reduce the de
  •   Read More
Xofigo (radium Ra 223 dichloride) - FDA

Description : Radium Ra 223 dichloride, an alpha particle-emitting pharmaceutical, is a radiotherapeutic ...

  • Indications
  • Xofigo is indicated for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease.
  •   Read More
Xofigo radium Ra 223 dichloride) - FDA

Description : Radium Ra 223 dichloride, an alpha particle-emitting pharmaceutical, is a radiotherapeutic drug...

  • Indications
  • Xofigo is indicated for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease.
  •   Read More
Xolair omalizumab (Pronunciation: OH ma LIZ oo mab) - FDA

Description : Xolair is a recombinant DNA-derived humanized IgG1τ monoclonal antibody that selective...

  • Indications
  • Asthma Xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reac
  •   Read More
Xolair omalizumab (Pronunciation: OH ma LIZ oo mab) - FDA

Description : Xolair is a recombinant DNA-derived humanized IgG1τ monoclonal antibody that selectively b...

  • Indications
  • Asthma Xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reac
  •   Read More
Xopenex, Xopenex Concentrate levalbuterol inhalation (Pronunciation: leh val BY - FDA

Description : XOPENEX Inhalation Solution is a sterile, clear, colorless, preservative-free solution of t...

  • Indications
  • XOPENEX (levalbuterol HCl) Inhalation Solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older w
  •   Read More
Xopenex, Xopenex Concentrate levalbuterol inhalation (Pronunciation: leh val BY - Multum

Description : XOPENEX Inhalation Solution is a sterile, clear, colorless, preservative-free solution of t...

  • Indications
  • XOPENEX (levalbuterol HCl) Inhalation Solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older w
  •   Read More
Xopenex, Xopenex Concentrate levalbuterol inhalation (Pronunciation: leh val BY - FDA

Description : The active component of XOPENEX HFA is levalbuterol tartrate, the (R)-enantiomer of albuter...

  • Indications
  • Bronchospasm XOPENEX HFA is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstru
  •   Read More
Xopenex, Xopenex Concentrate levalbuterol inhalation (Pronunciation: leh val BY - Multum

Description : The active component of XOPENEX HFA is levalbuterol tartrate, the (R)-enantiomer of albuter...

  • Indications
  • Bronchospasm XOPENEX HFA is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstru
  •   Read More
Xopenex, Xopenex Concentrate  levalbuterol inhalation (Pronunciation: leh val B - FDA

Description : XOPENEX Inhalation Solution is a sterile, clear, colorless, preservative-free solution of the h...

  • Indications
  • XOPENEX (levalbuterol HCl) Inhalation Solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with
  •   Read More
Xopenex, Xopenex Concentrate  levalbuterol inhalation (Pronunciation: leh val B - Multum

Description : XOPENEX Inhalation Solution is a sterile, clear, colorless, preservative-free solution of the h...

  • Indications
  • XOPENEX (levalbuterol HCl) Inhalation Solution is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with
  •   Read More
Xopenex, Xopenex Concentrate  levalbuterol inhalation (Pronunciation: leh val B - Multum

Description : The active component of XOPENEX HFA inhalation aerosol is levalbuterol tartrate, the (R)enantio...

  • Indications
  • Bronchospasm XOPENEX HFA is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 4 years of age and older with reversible obstru
  •   Read More
Xtandi enzalutamide (Pronunciation: ENZ a LOOT a mide) - FDA

Description : Enzalutamide is an androgen receptor inhibitor. The chemical name is 4-{3-[4-cyano-3-...

  • Indications
  • XTANDI is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).
  •   Read More
Xtandi enzalutamide (Pronunciation: ENZ a LOOT a mide) - Multum

Description : Enzalutamide is an androgen receptor inhibitor. The chemical name is 4-{3-[4-cyano-3-...

  • Indications
  • XTANDI is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).
  •   Read More
Xtandi enzalutamide (Pronunciation: ENZ a LOOT a mide) - FDA

Description : Enzalutamide is an androgen receptor inhibitor. The chemical name is 4-{3-[4-cyano-3-(trifluor...

  • Indications
  • XTANDI is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).
  •   Read More
Xtandi enzalutamide (Pronunciation: ENZ a LOOT a mide) - Multum

Description : Enzalutamide is an androgen receptor inhibitor. The chemical name is 4-{3-[4-cyano-3-(trifluor...

  • Indications
  • XTANDI is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).
  •   Read More
Xtoro (finafloxacin) Otic Suspension - FDA

Description : XTORO (finafloxacin otic suspension), 0.3% is a quinolone antimicrobial. Its chemical name...

  • Indications
  • XTORO* (finafloxacin otic suspension), 0.3% is indicated for the treatment of acute otitis externa (AOE) with or without an otowick, caused by susceptible strains of Pseudomon
  •   Read More
Xtoro (finafloxacin) Otic Suspension - FDA

Description : XTORO (finafloxacin otic suspension), 0.3% is a quinolone antimicrobial. Its chemical name is ...

  • Indications
  • XTORO* (finafloxacin otic suspension), 0.3% is indicated for the treatment of acute otitis externa (AOE) with or without an otowick, caused by susceptible strains of Pseudomon
  •   Read More
Xylocaine Viscous lidocaine viscous (Pronunciation: LYE doe kane VIS - FDA

Description : SUMMARY PRODUCT INFORMATION Route of Administration Dosage Form / Strength Clin...

  • Indications
  • Xylocaine (lidocaine HCl) 2% Viscous Solution is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. It is a
  •   Read More
Xylocaine Viscous lidocaine viscous (Pronunciation: LYE doe kane VIS - Multum

Description : SUMMARY PRODUCT INFORMATION Route of Administration Dosage Form / Strength Clin...

  • Indications
  • Xylocaine (lidocaine HCl) 2% Viscous Solution is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. It
  •   Read More
Xylocaine Viscous  lidocaine viscous (Pronunciation: LYE doe kane VI - FDA

Description : SUMMARY PRODUCT INFORMATION Route of Administration Dosage Form / Strength Clinical...

  • Indications
  • Xylocaine (lidocaine HCl) 2% Viscous Solution is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. It is a
  •   Read More
Xylocaine Viscous lidocaine viscous (Pronunciation: LYE doe kane VIS - Multum

Description : SUMMARY PRODUCT INFORMATION Route of Administration Dosage Form / Strength Clinical...

  • Indications
  • Xylocaine (lidocaine HCl) 2% Viscous Solution is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. It is a
  •   Read More
Xyntha Antihemophilic Factor (Recombinant), Plasma/Albumi - FDA

Description : Antihemophilic Factor (Recombinant), Plasma/Albumin-Free, the active ingredient in XYNTHA, ...

  • Indications
  • Control of Bleeding Episodes in Hemophilia A XYNTHA Antihemophilic Factor (Recombinant), Plasma/Albumin-Free is indicated for the control and prevention of bleeding episo
  •   Read More
Xyntha Antihemophilic Factor (Recombinant), Plasma/Albumi - FDA

Description : Antihemophilic Factor (Recombinant), Plasma/Albumin-Free, the active ingredient in XYNTHA, is a...

  • Indications
  • Control of Bleeding Episodes in Hemophilia A XYNTHA Antihemophilic Factor (Recombinant), Plasma/Albumin-Free is indicated for the control and prevention of bleeding episo
  •   Read More
Xyrem sodium oxybate (Pronunciation: SO dee um OX i bate - Multum

Description : Sodium oxybate, a CNS depressant, is the active ingredient in Xyrem. The chemical name for sodi...

  • Indications
  • Limitations of Use Xyrem may only be dispensed to patients enrolled in the Xyrem Success Program [see WARNINGS AND PRECAUTIONS]. Cataplexy In Narcolepsy Xyrem (sodium o
  •   Read More
Xyrem sodium oxybate (Pronunciation: SO dee um OX i bate - FDA

Description : Sodium oxybate, a CNS depressant, is the active ingredient in Xyrem. The chemical name for sodi...

  • Indications
  • Limitations of Use Xyrem may only be dispensed to patients enrolled in the Xyrem Success Program [see WARNINGS AND PRECAUTIONS]. Cataplexy In Narcolepsy Xyrem (sodium o
  •   Read More
Xyrem sodium oxybate (Pronunciation: SO dee um OX i bate - Multum

Description : Sodium oxybate, a CNS depressant, is the active ingredient in Xyrem. The chemical name for sodi...

  • Indications
  • Limitations of Use Xyrem may only be dispensed to patients enrolled in the Xyrem Success Program [see WARNINGS AND PRECAUTIONS]. Cataplexy In Narcolepsy Xyrem (sodium o
  •   Read More
Xyzal levocetirizine (Pronunciation: LEE voe se TIR a ze - FDA

Description : Levocetirizine dihydrochloride, the active component of XYZAL tablets and oral solution, is...

  • Indications
  • Seasonal Allergic Rhinitis XYZAL® is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older.
  •   Read More
Xyzal levocetirizine (Pronunciation: LEE voe se TIR a ze - Multum

Description : Levocetirizine dihydrochloride, the active component of XYZAL tablets and oral solution, is...

  • Indications
  • Seasonal Allergic Rhinitis XYZAL® is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older.
  •   Read More
Xyzal levocetirizine (Pronunciation: LEE voe se TIR a ze - Multum

Description : Levocetirizine dihydrochloride, the active component of XYZAL tablets and oral solution, is an ...

  • Indications
  • Seasonal Allergic Rhinitis XYZAL® is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older.
  •   Read More
Rx Scoops
Featured Topics
Advertisements
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI